ArticleFrontiers in nutrition2025
Isolation and identification of lactic acid bacteria from ginseng sprouts and research on their probiotic, anti-inflammatory, and anti-cancer activity.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Complete genome sequence of Lacticaseibacillus rhamnosus B34-0-2 isolated from Panax ginseng in South Korea.BMC genomic data · 2026Article
- Complete genome sequence of Leuconostoc lactis B34-1-7-1 isolated from Panax ginseng in South Korea.BMC genomic data · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ginseng sprouts are recognized as a potentially valuable food source as they provide an abundance of bioactive compounds with antioxidants and anti-cancer properties. This study investigates the probiotic properties of lactic acid bacteria (LAB) from ginseng sprouts, addressing gaps in plant-based probiotic discovery. Methods: A total of 17 putative LAB strains were obtained from 688 bacterial isolates from ginseng sprouts. Molecular identification via 16S rRNA sequencing classified and selected five isolates as LAB taxa. Their probiotic potential was evaluated through Results: After 16S rRNA sequencing, five candidate probiotic strains from ginseng sprouts were identified, including three strains of Conclusion: These findings highlight the therapeutic promise of plant-derived probiotic bacterial strains for potential applications in human health, particularly in inflammation and cancer prevention. Moreover, the successful isolation of probiotic LAB from ginseng sprouts underscores the potential of ginseng as a valuable source of health-promoting microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.